Archives of Toxicology

, Volume 81, Issue 12, pp 825–832

Subacute oral toxicity study of bisphenol F based on the draft protocol for the “Enhanced OECD Test Guideline no. 407”

  • Nobuhiko Higashihara
  • Keiji Shiraishi
  • Katusi Miyata
  • Yutaka Oshima
  • Yasushi Minobe
  • Kanji Yamasaki
Inorganic Compounds

DOI: 10.1007/s00204-007-0223-4

Cite this article as:
Higashihara, N., Shiraishi, K., Miyata, K. et al. Arch Toxicol (2007) 81: 825. doi:10.1007/s00204-007-0223-4

Abstract

Since bisphenol F (4,4’-dihydroxydiphenylmethane) has been reported to exhibit estrogen agonistic properties in the uterotrophic assay, we performed a 28-day repeated-dose toxicity study (enhanced OECD test guideline No. 407) on bisphenol F based on the OECD draft protocols to determine whether it has endocrine-mediated properties. Bisphenol F was orally administered at doses 0, 20, 100 and 500 mg/kg per day for at least 28 days, but no clear endocrine-mediated changes were detected, and it was concluded to have no endocrine-mediated effects in young adult rats. On the other hand, the main effect of bisphenol F was concluded to be liver toxicity based on clinical biochemical parameters and liver weight, but without histopathological changes. The no-observed-effect level for bisphenol F is concluded to be under 20 mg/kg per day since decreased body weight accompanied by decreased serum total cholesterol, glucose, and albumin values were observed in the female rats given 20 mg/kg per day or higher doses of bisphenol F.

Keywords

Bisphenol F Enhanced Test Guideline 407 Rat Endocrine effects 

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Nobuhiko Higashihara
    • 1
  • Keiji Shiraishi
    • 1
  • Katusi Miyata
    • 1
  • Yutaka Oshima
    • 1
  • Yasushi Minobe
    • 1
  • Kanji Yamasaki
    • 1
  1. 1.Chemicals Evaluation and Research InstituteOitaJapan

Personalised recommendations